EYEGATE PHARMACEUTICALS INC 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Apr 27, 2016
Insider Transaction Report
Form 4
Brenneman Ryan Randall
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-04-25+41,732→ 41,732 totalExercise: $3.23Exp: 2026-04-25→ Common Stock (41,732 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 25, 2017, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the Reporting Person's continued employment through each such vesting date.